Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QuatRx Pharmaceuticals Co

Latest From QuatRx Pharmaceuticals Co

Deal Watch: Cidara Licenses US Rights To Antifungal Under FDA Review To Melinta

Cidara gets $30m up front for US rights to the weekly echinocandin candidate for candidemia and invasive candidiasis. Takeda walks away from oncolytic virus candidate licensed from Turnstone.

Deal Watch Business Strategies

Execs On The Move: April 2022

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Commercial Companies

Execs On The Move, April 2022 Roundup: Shake Ups At Glaukos, Medtronic, BD And Globus

Executives On The Move will be running to a monthly schedule from now, with this edition covering medtech's executive changes for April.

Executive Changes Commercial

Finance Watch: HilleVax, Belite Bio Launch First Two Biopharma IPOs In Q2

Also, Cytovia will go public via SPAC merger, Nkarta capitalized on its positive early NK cell therapy data with a $230m offering, and venture capital mega-rounds include $220m for Reify, $110m for Satellite Bio and $100m for OMass Therapeutics. 

Financing Innovation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Other Names / Subsidiaries
    • Hormos Medical
UsernamePublicRestriction

Register